Execution Without Direction: The Hidden Risk in Outsourced Clinical Trials

As clinical trials become increasingly outsourced, a critical gap has emerged between sponsor expectations and CRO execution. Many smaller biotech companies rely heavily on outsourcing vendors to drive their programs, often without the internal clinical operations infrastructure needed to provide direction, oversight, and strategic alignment.

At the same time, vendor teams—particularly CRAs—are frequently stretched thin and charged with executing small tasks without understanding the bigger picture. The result is a growing disconnect: between sponsors and CROs, CRAs and sites, and protocols and real-world operations. These gaps can lead to inefficiencies, risks, and strained site relationships that ultimately impact study success.

In this live webinar, industry experts will explore the root causes of this disconnect and examine whether clinical oversight monitors are a necessary evolution, or an added layer of complexity. Through real-world insights and practical examples, we’ll discuss how organizations can better align stakeholders, improve trial execution, and close the widening operational gap.

In this webinar, you will:
– Understand the structural gaps that commonly exist between sponsors, CROs, and clinical sites
– Learn why traditional CRO models may fall short in providing strategic clinical oversight
– Identify the risks and inefficiencies that arise from fragmented clinical operations
– Explore the role of oversight functions in improving alignment, quality, and site relationships
– Gain practical strategies for strengthening collaboration and ensuring more cohesive trial execution